<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Deb B</submitter><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>e2600-e2609</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8807322</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>107(6)</volume><pubmed_abstract>&lt;h4>Context&lt;/h4>SARS-CoV-2 infects the gastrointestinal tract and may be associated with symptoms that resemble diabetic gastroparesis. Why patients with diabetes who contract COVID-19 are more likely to have severe disease is unknown.&lt;h4>Objective&lt;/h4>We aimed to compare the duodenal mucosal expression of SARS-CoV-2 and inflammation-related genes in diabetes gastroenteropathy (DGE), functional dyspepsia (FD), and healthy controls.&lt;h4>Methods&lt;/h4>Gastrointestinal transit, and duodenal mucosal mRNA expression of selected genes were compared in 21 controls, 39 DGE patients, and 37 FD patients from a tertiary referral center. Pathway analyses were performed.&lt;h4>Results&lt;/h4>Patients had normal, delayed (5 FD [13%] and 13 DGE patients [33%]; P = 0.03 vs controls), or rapid (5 FD [12%] and 5 DGE</pubmed_abstract><journal>The Journal of clinical endocrinology and metabolism</journal><pubmed_title>Duodenal Mucosal Expression of COVID-19-Related Genes in Health, Diabetic Gastroenteropathy, and Functional Dyspepsia.</pubmed_title><pmcid>PMC8807322</pmcid><funding_grant_id>R01 DK68055</funding_grant_id><pubmed_authors>Bharucha AE</pubmed_authors><pubmed_authors>Chunawala ZS</pubmed_authors><pubmed_authors>O'Brien DR</pubmed_authors><pubmed_authors>Deb B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Duodenal Mucosal Expression of COVID-19-Related Genes in Health, Diabetic Gastroenteropathy, and Functional Dyspepsia.</name><description>&lt;h4>Context&lt;/h4>SARS-CoV-2 infects the gastrointestinal tract and may be associated with symptoms that resemble diabetic gastroparesis. Why patients with diabetes who contract COVID-19 are more likely to have severe disease is unknown.&lt;h4>Objective&lt;/h4>We aimed to compare the duodenal mucosal expression of SARS-CoV-2 and inflammation-related genes in diabetes gastroenteropathy (DGE), functional dyspepsia (FD), and healthy controls.&lt;h4>Methods&lt;/h4>Gastrointestinal transit, and duodenal mucosal mRNA expression of selected genes were compared in 21 controls, 39 DGE patients, and 37 FD patients from a tertiary referral center. Pathway analyses were performed.&lt;h4>Results&lt;/h4>Patients had normal, delayed (5 FD [13%] and 13 DGE patients [33%]; P = 0.03 vs controls), or rapid (5 FD [12%] and 5 DGE</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-05-18T12:04:42.56Z</modification><creation>2025-04-05T20:41:12.775Z</creation></dates><accession>S-EPMC8807322</accession><cross_references><pubmed>35090021</pubmed><doi>10.1210/clinem/dgac038</doi></cross_references></HashMap>